|
|
Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats
|
1R01CA182284-01A1
|
$346,525
|
$346,525
|
COLE, PETER
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$1,500
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$2,970
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$71,705
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Nemours Community Clinical Oncology Program
|
3U10CA176879-01S1
|
$89,460
|
$33,100
|
SANDLER, ERIC
|
ALFRED I. DU PONT HOSP FOR CHILDREN
|
|
|
Germline Telomere Biology Defects in Pediatric and Young Adult Acute Myeloid Leuk
|
5K23CA158148-03
|
$168,757
|
$168,757
|
GRAMATGES, MARIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
3R01CA164024-02S1
|
$3,941
|
$3,941
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML
|
5R01CA164024-02
|
$322,104
|
$322,104
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$488
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$1,498
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$27,467
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
2P01CA066996-16A1
|
$2,307,647
|
$276,918
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
COG NCTN Network Group Operations Center
|
1U10CA180886-01
|
$26,616,497
|
$8,916,526
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S1
|
$79,593
|
$26,664
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S2
|
$208,457
|
$69,833
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S3
|
$229,232
|
$76,793
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S4
|
$1,163,256
|
$389,691
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S5
|
$1,543,656
|
$517,125
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S6
|
$265,465
|
$88,931
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-01S7
|
$3,000,000
|
$1,005,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Genetic Predictors of AML Treatment Response
|
5R01CA133881-05
|
$455,264
|
$455,264
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Toxicity Monitoring on Phase III Trials with Administrative Data
|
5R01CA165277-03
|
$397,781
|
$397,781
|
APLENC, RICHARD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
MLL in Hematopoiesis and Leukemia in the Zebrafish Model
|
5R01CA153348-05
|
$384,562
|
$384,562
|
FELIX, CAROLYN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
Bone Deficits and Excess Adiposity after Pediatric Bone Marrow Transplantation
|
5K07CA166177-02
|
$164,971
|
$164,971
|
MOSTOUFI-MOAB, SOGOL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia
|
1K08CA184418-01A1
|
$169,657
|
$169,657
|
TASIAN, SARAH
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-10
|
$315,782
|
$78,946
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL CORPORATION
|
|
|
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
|
5U54CA163117-04
|
$473,452
|
$127,832
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
|
5R01CA172896-02
|
$328,604
|
$328,604
|
KIM, YONG-MI
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Targeting SYK Tyrosine Kinase to Overcome Radiation Resistance in ALL
|
5R01CA154471-04
|
$322,040
|
$322,040
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Targeting SYK Kinase in B-Lineage ALL with CD19-Specific C-61 Nanoparticles
|
5U01CA151837-05
|
$417,323
|
$417,323
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
|
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
|
1U01CA183030-01
|
$653,666
|
$653,666
|
LIU, YANG
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
A Novel Epigenetic Circuit in Acute Leukemia
|
1R21CA187276-01
|
$169,650
|
$169,650
|
HUANG, GANG
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
5R01CA157537-04
|
$307,951
|
$307,951
|
PANG, QISHEN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
|
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukemia
|
1R01CA174683-01A1
|
$747,876
|
$747,876
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$4,875
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$2,563
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$5,050
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$504
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$84,762
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Targeting non-classical oncogenes as therapy for T-ALL
|
5R01CA169162-03
|
$322,040
|
$161,020
|
DIACOVO, THOMAS
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
2P30CA013696-40
|
$3,596,904
|
$71,938
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-40S1
|
$125,000
|
$2,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-40S2
|
$50,000
|
$1,000
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-40S3
|
$320,000
|
$6,400
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA013696-40S4
|
$75,000
|
$1,500
|
EMERSON, STEPHEN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of PHF6 in T-cell acute lymphoblastic leukemia
|
5R01CA155743-04
|
$322,040
|
$322,040
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The role of ETV6 in T-cell acute lymphoblastic leukemia
|
5R01CA172398-02
|
$322,040
|
$161,020
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Role of FBXL4 in T-cell Acute Lymphoblastic Leukemia
|
5F30CA174099-02
|
$42,273
|
$21,137
|
HAYDU, JULIE-ERIKA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Cancer Center Support Grant
|
3P30CA006516-49S1
|
$118,825
|
$2,377
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Total relevant funding to Childhood Leukemia for this search: $55,209,492
|
